
The AIHTA is responsible for systematically assessing the comparative effectiveness and safety of these new interventions. Topics are prioritised by a working group of the Federal Health Agency, comprising representatives of the Ministry (BMASGPK), the States (Bundesländer) and the social insurance institutions. The assessment is based on systematic reviews and a presentation of the evidence according to the GRADE framework.
Evaluation of Individual Medical Procedures - Reports
- DSD 148: Transarterial periarticular embolisation (TAPE) for knee and shoulder osteoarthritis
- DSD 147: Pharyngeal electrical stimulation for neurogenic oropharyngeal dysphagia
- Update / DSD 119/ 1. Update: Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure
- DSD 146: Einzeitiger Matrix-assistierter Knorpelersatz mit und ohne Knochenmarkaspiratkonzentrat im Knie
- DSD 145: Thermoablation bei Brustkrebs im Frühstadium: Kryoablation, Mikrowellen, Radiofrequenz, hochintensiver fokussierter Ultraschall und Laserablation
- DSD 144: Medikamentenbeschichteter Ballonkatheter zur Behandlung der Harnröhrenstriktur
- DSD 143: Inselzelltransplantation bei Pankreatektomie, Typ-1-Diabetes mit schweren Hypoglykämien und Nierentransplantation
- Update / DSD 129: Temporäre Nitinol-Implantation (TIND) bei gutartiger Prostatavergrößerung
- Update / DSD 97: Sondenlose Herzschrittmacher. 3. Update 2025
- DSD 141: Thermoablation von benignen Schilddrüsenknoten
- DSD 140: Elektrokonvulsionstherapie bei therapieresistenter Depression und therapieresistenter Schizophrenie
- DSD 139: Perkutane transfemorale heterotope Trikuspidalklappenersatz (CAVI) bei Trikuspidalinsuffizienz
- Update / DSD 45/2. Update 2024: Perkutane renale Denervation bei therapieresistenter Hypertonie
- Update / DSD 24/3. Update 2024: Perkutane transluminale koronare Angioplastie (PTCA) mit drug-eluting balloon (DEB)
- DSD 138: Elektrische aurikuläre Vagus Nervenstimulation bei Schmerzen
- DSD 137: Bleomycin-Elektrosklerotherapie bei Vaskulären Anomalien: Systematische Übersichtsarbeit
- DSD 136: Transkranielle Magnetresonanz-gesteuerte hochintensive fokussierte Ultraschallbehandlung bei Patient*innen mit medikamentenresistentem essentiellen Tremor
- DSD 135: Perkutane Aspirationsthrombektomie bei Lungenembolie
- Update / DSD 118/1. Update 2023: 177Lu-PSMA-Radioligandentherapie bei Patienten mit metastasiertem kastrationsresistentem Prostatakrebs: Systematische Übersichtsarbeit
- Update / DSD 111/1. Update 2023: Allogene mesenchymale Stammzellen bei PatientInnen mit Morbus Crohn-assoziierten, komplexen, perianalen Fisteln
- Update / DSD 41/2. Update 2023: Perkutane Mitralklappenintervention mittels Mitralclip bei Mitralklappeninsuffizienz
- DSD 134: Laparoskopische Reflux-Management-Verfahren für den unteren Ösophagussphinkter (UÖS) bei Patient*innen mit GERD
- DSD 133: Chemosaturation mit perkutaner Leberperfusion für Patient*innen mit Leberkrebs
- DSD 132: His-bundle-pacing zur Stimulation des kardialen Reizleitungssystems
- DSD 131: Mikrowellenablation bei Lebertumoren
- DSD 130: Lebervenen- und Pfortaderembolisation vor einer Major-Leberresektion
- Update / DSD 121: Perkutane transvaskuläre Implantation eines Stents zur Verengung des Koronarsinus
- Update / DSD 109: Subcutaneous implantable cardioverter-defibrillator (S-ICD)
- Update / DSD 100: Stimulation der oberen Atemwege bei mittelschwerer bis schwerer Schlafapnoe
Stellungnahme von Inspire Medical Systems, Inc.
Antwort des AIHTA - Update / DSD 74: Zytoreduktive Chirurgie und hypertherme intraperitoneale Chemotherapie bei sekundärer Peritonealkarzinose
(Master Arbeit / nicht im Auftrag des BMSGPK erstellt) - Update / DSD 64: Perkutane koronare Interventionen (PCI) bei chronischen Komplettverschlüssen (CTO)
- DSD 129: Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia
- DSD 128: Allogenic bone screw Shark Screw® in patients with hallux valgus or scaphoid fractures/pseudarthroses
- DSD 127: Endoscopic plication therapy in patients with gastroesophageal reflux disease (GERD)
- DSD 126: Triphasic biomaterial for augmentation of the osteoporotic femoral neck
- DSD 125: Liposuction for surgical therapy of lipoedema
- DSD 124: Percutaneous left ventricular assist devices: micro-axial flow pumps
- Update / DSD 87/1. Update 2021: Implantation of Bulking Agents for Faecal Incontinence
- DSD 123: Vaskuläre photodynamische Therapie mit Padeliporfin (Tookad® Lösung)
- DSD 122: Radiofrequency-Induced Intravesical Chemohyperthermia for Non-Muscle-Invasive Bladder Cancerm
- DSD 121: Percutaneous Transvascular Implantation of a Coronary Sinus Reducing Stent
- DSD 120: Intrauterine ultrasound-guided transcervical radiofrequency ablation
- DSD 119: Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure’
- Update / DSD 106/Update 2020: Extracorporeal cytokine haemadsorption therapy in patients with sepsis or SIRS
- Update / DSD 97/2. Update 2020: Leadless pacemaker for right ventricle pacing
- DSD 118: 177Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
- DSD 117: Human dermal allograft for massive rotator cuff tears
- DSD 116: Allograft for anterior and posterior cruciate ligament reconstruction
- DSD 115: Osteochondral allograft transplantation for the knee (or other joints)
- Update / DSD 100/1. Update 2019: Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea
- Update / DSD 99/1. Update 2019: Radiofrequency denervation for lumbar and cervical facet joint pain – a systematic review
- Update / DSD 98/1. Update 2019: Single-/two-step scaffold-based cartilage repair in the knee and ankle joint
- Update / DSD 65/1. Update 2019: Annulus Fibrosus Repair after lumbar discectom
- DSD 113: Baroreceptor activation therapy for treatment-resitant hypertension
- DSD 112: Meniscal allograft transplantation
- DSD 111: Allogeneic mesenchymal stem cells for Crohn’s disease-associated complex perianal fistulas
- DSD 110: Lymphovenous anastomoses in patients with primary and secondary lymphedema
- DSD 109: Subcutaneous implantable cardioverter defibrillator (ICD)
- Update / DSD 44/3. Update 2018: Left Atrial Appendage Closure for the prevention of thrombo-embolic events in patients with atrial fibrillation
- Update / DSD 37/1.Update 2018: High intensity focused ultrasound (HIFU) for the treatment of prostate cancer
- Update / DSD 20//4. Update 2018: Endobronchial valve implantation for emphysema
- DSD 108: Radiofrequency ablation for metastatic spinal lesions
- DSD 107: Repetitive transcranial magnetic stimulation for treatment-resistant major depression
- DSD 106: Extracorporeal cytokine haemadsorption therapy in patients with sepsis or SIRS
- DSD 105: Prostate artery embolisation for benign prostatic hyperplasia
- DSD 104: Electric stimulation therapy (EST) in patients with gastroesophageal reflux disease (GERD)
- Update / DSD 97/Update 2017: Leadless pacemakers for right ventricle pacing
- Update / DSD 21/Update 2017: Percutaneous disc volume reduction – chemonucleolysis
- DSD 101: Magnetic sphincter augmentation device (MSAD) in patients with gastroesophageal reflux disease (GERD)
- DSD 100: Upper airway stimulation for moderate-to-severe sleep apnea
- DSD 99: Radiofrequency denervation for sacroiliac and facet joint pain
- DSD 98: Single-step scaffold-based cartilage repair in the knee
- DSD 97: Leadless pacemakers for right ventricle pacin
- Update / DSD 24/Update 2016: Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB)
- DSD 87: Injectable bulking agents for faecal incontinence
- DSD 86: Sphenopalatine Ganglion (SPG) stimulation of patients with therapy-resistant cluster headache
- DSD 85: Intrastromal corneal implants for ectatic corneal disorders
- DSD 84: Defibrotide for the treatment and prophylaxis of hepatic veno-occlusive disease
- DSD 83: Endovascular embolization of unruptured intracranial aneurysms with flow diverters
- DSD 82: Transcatheter mitral valve-in-valve implantation (TMViVI)
- DSD 81: Fully bioresorbable scaffolds for coronary artery disease
- Update / DSD 68/ 1st Update 2015: Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB)
- Update / DSD 44/ 2nd Update 2015: Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation
- DSD 76: Stereotactic Radiofrequency ablation/ SRFA for hepatocellular carcinoma and liver metastases
- DSD 75: Drug eluting stents for the treatment of peripheral artery disease
- DSD 74: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of peritoneal carcinomatosis
- Update / DSD 44/1. Update 2014: Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation
- Update / DSD 20/ Update 2014: Implantation of endobronchial valves in patients with emphysema
- DSD 71: Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM)
- DSD 70: Percutaneous transcatheter closure of prosthetic mitral and aortic paravalvular leaks
- DSD 69: Endovascular repair of aortic aneurysms
- DSD 68: Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB)
- DSD 67: Duodeno-jejunal bypass liner (DJBL) for patients with obesity
- DSD 66: Repair of cartilage defects via matrix-asocciated autologous chondrocyte immigration
- DSD 65: Implantation of a lumbar artificial endoprosthesis (anuloplasty/ anular repair device)
- Letter to the editor
- Response to the letter - DSD 64: Percutaneous coronary intervention for chronic total occlusion
- Update / DSD 24/ Update 2013: Percuteneous transluminal coronary angioplasty (PTCA) with paclitaxel-coated drug-eluting balloon (DEB) (1st Update)
- DSD 60: Sling suspension in male urinary incontinence
- DSD 59: Radiofrequency Ablation for Treatment of Tumors of the Urogenital Tract (Renal Cell Carcinoma, Prostate Cancer and Uterine Leiomyoma)
- DSD 58: Radiofrequency ablation of primary tumors of the gastrointestinal tract (colorectal and pancreatic cancer)
- DSD 57: Radiofrequency Ablation for Treatment of Breast Cancer
- DSD 56: Radiofrequency Ablation for Treatment of Benign and Malignant Lesions of Endocrine Organs (Thyroid and Adrenal Gland)
- DSD 55: Radiofrequency Ablation for Treatment of Head and Neck Cancer
- DSD 54: Radiofrequency ablation of bone tumors (osteoid-osteoma and osseous metastases)
- DSD 53: Radiofrequency ablation of tumors of the lung and mediastinal lymph nodes
- Update / DSD 45/ Update 2012: Renal denervation in patients with essential hypertension
- Update / DSD 41/ Update 2012: Percutaneous repair of mitral regurgitation with the MitraClip
- Update / DSD 23/ Update 2012: Intraoperative radiotherapy for primary breast cancer
- Update / DSD 06/ Update 2012: Cell therapy for urinary stress incontinence
- DSD 47: Selective internal radiotherapy using yttrium-90 microspheres for primary and secondary liver malignanciesDSD 43: Vascular-Endothelial-Growth-Factor-Inhibitors (anti-VEGF) in the Management of Diabetic Macular Oedema
DSD 46: Mechanical percutaneous transluminal cerebral clot retrieval devices in acute ischemic stroke: Systematic Review on efficacy and safety - DSD 45: Renal denervation in patients with essential hypertonia
- DSD 44: Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation
- Update / DSD 18/Update 2011: Percutaneous aortic valve replacement (with a side note to hybrid operating rooms)
- DSD 41: Mitral valve repair using a mitral clip
- DSD 40: Radionuclide therapy - 90Yttrium and 177Lutetium somatostatin analogues for the treatment of inoperable neuroendocrine tumors
- DSD 39: Laser angioplasty of coronary arteries
- DSD 38: Artificial disc replacement
- DSD 37: High intensity focused ultrasound (HIFU) for the treatment of prostate cancer
- Update / DSD 20/ Update 2010: Endobronchial valve implantation for emphysema
- Update / DSD 18/ Update 2010: Percutaneous aortic valve replacement
- Update / DSD 15/ Update 2010: Cardiac contractility modulation for heart failure
- Update / DSD 14/ Addendum 2010: Stent-grafting of the ascending aorta
- Update / DSD 08/ Update 2010: Kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures
- DSD 30: Retroluminal transobturatoric reposition sling for the treatment of stress urinary incontinence in men
- DSD 27: Pumpless extracorporeal lung assist (PECLA)
- DSD 26: Image guided radiotherapy using cone-beam computed tomography
- DSD 25: Selective IgG Apheresis for ABO-incompatible kidney transplantation
- DSD 24: Drug coated balloon catheter
- DSD 23: Intraoperative radiotherapy for primary breast cancer
- DSD 22: Injection therapies and radiofrequency for the treatment of chronic back pain
- DSD 21b: Percutaneous nucleotomy and percutaneours laser disk decompression
- DSD 21a: Chemonucleolysis and intradiscal electrotherapy (IDET)
- Update / DSD 20/ Update 2009: Endobronchial valve implantation for emphysema- Report not published
- Update / DSD 18/ Update 2009: Percutaneous aortic valve replacement
- Update / DSD 15/ Update 2009: Cardiac contractility modulation for heart failure
- Update / DSD 14/ Update 2009: Stent-grafting of the ascending aorta
- DSD 20: Endobronchial valve implantation for emphysema - Report not published
- DSD 18: Percutaneous aortic valve replacement
- DSD 15: Cardiac contractility modulation for heart failure
- DSD 14: Stent-grafting of the ascending aorta
- DSD 13: Optical Coherence Tomography
- DSD 12: Rheopheresis® in patients with age-related macular degeneration, sudden hearing loss or tinnitus, diabetes
- DSD 11: Selective Cell Apheresis in Inflammatory Bowel Disease
- DSD 10: Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction in patients with congenital heart defects
- DSD 8: Kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures
- DSD 7: LDL apheresis
- DSD 6: New minimally invasive methods in the treatment of stress urinary incontinence